Tanglewood Legacy Advisors, LLC Novo Nordisk A S Transaction History

Tanglewood Legacy Advisors, LLC

  • $225 Billion
  • Q3 2024

A detailed history of Tanglewood Legacy Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Tanglewood Legacy Advisors, LLC holds 790 shares of NVO stock, worth $66,383. This represents 0.04% of its overall portfolio holdings.

Number of Shares
790
Previous 790 -0.0%
Holding current value
$66,383
Previous $113 Million 16.58%
% of portfolio
0.04%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 18, 2023
BUY
$90.94 - $199.54 $35,921 - $78,818
395 Added 100.0%
790 $71.8 Million
Q4 2022

Feb 13, 2023
BUY
$102.55 - $135.33 $40,507 - $53,455
395 New
395 $53.5 Million

Others Institutions Holding NVO

# of Institutions
1,879
Shares Held
317M
Call Options Held
5.49M
Put Options Held
7.77M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $190B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Tanglewood Legacy Advisors, LLC Portfolio

Follow Tanglewood Legacy Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tanglewood Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tanglewood Legacy Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email